- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05390398
Study on Fatigue in Colorectal Cancer Survivors, a Lifestyle Intervention (SoFiT)
Study Overview
Status
Intervention / Treatment
Detailed Description
The SoFiT study is a randomized controlled trial examining the effects of a behaviour change guided lifestyle intervention on increasing adherence to the World Cancer Research Fund (WCRF) cancer prevention guidelines, compared to the wait-list usual care group, on diminishing cancer-related fatigue in colorectal cancer survivors.
Colorectal cancer survivors who completed treatment six months to five years ago and who suffer from cancer-related fatigue, are randomized into two parallel groups: an intervention group or the wait-list usual care group. The intervention group follows a six-month personalized lifestyle program, which is guided by behaviour change techniques, to increase adherence to the World Cancer Research Fund cancer prevention guidelines on healthy nutrition, physical activity and healthy weight. Participants are guided by a lifestyle coach specialized in behaviour change. The wait-list usual care group receives a lifestyle program after the intervention period of six months: this includes two personalized behavioural coaching sessions and any material that the intervention group also received.
Both groups participate in measurements at baseline, three months, at the end of the intervention (six months) and at follow-up (twelve months). The follow-up timepoint is included to study long-term behavioural lifestyle change. The primary outcome is the change in cancer-related fatigue, as measured by the FACIT-Fatigue questionnaire, between the intervention and wait-list usual care group from baseline till six months.
Secondary outcomes include cancer-related fatigue (at other timepoints), skeletal muscle fat infiltration and cross-sectional area, gut microbiota composition, health-related quality of life, physical performance, sleep quality and duration, depression and anxiety, behavioural determinants and adherence to the WCRF guidelines by assessing habitual dietary intake, physical activity level, height, weight, waist circumference and BMI. Other outcomes of interest include, blood pressure, chrono-nutrition, colorectal cancer related complaints, hemoglobin blood levels, self-reported weight (at three months) and cost-effectiveness evaluation. Moreover, the following data will be collected to characterize the population: sociodemographic information (age, sex, marital status, education, smoking) and clinical parameters (time since diagnosis, current and received treatment, comorbidities, medicine and supplement use).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gelderland
-
Wageningen, Gelderland, Netherlands, 6708WE
- Wageningen University & Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 18 or above.
- Completed curative stage I-III colorectal cancer treatment in the previous 6 months to 5 years.
- Live on a reasonable distance from the research center at the Wageningen University & Research (WUR) (i.e. maximum of ± 1 hour away).
- Classified as suffering from CRF through the Functional Assessment of Chronic Illness Therapy (FACIT) - Fatigue Scale questionnaire with cut-off score below 34 indicating fatigue.
- Willingness to be randomized into either the intervention or wait-list control group.
- Willing and able to follow the lifestyle intervention.
- Able to understand and provide informed consent in Dutch.
Exclusion Criteria:
- Planning to participate or participating in another medical research that could possibly interfere with the study results.
- Excessive alcohol consumption (i.e. more than 4 glasses per day).
- Chronic drug use and unwillingly to stop using drugs.
- Unable/unwilling to comply with the intervention (e.g. through dementia, Alzheimer or mental illness)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
The intervention group follows a six-month personalized lifestyle program to increase adherence to the World Cancer Research Fund cancer prevention guidelines on healthy nutrition, physical activity and healthy weight.
|
Participants in the intervention group receive personalized coaching from a lifestyle coach on adhering to the World Cancer Research Fund cancer prevention guidelines.
The lifestyle coach is specialized in behaviour change techniques and uses these as the core of the lifestyle coaching.
For each participant behavioural determinants will be assessed and targeted with specific applicable behaviour change techniques.
|
No Intervention: Wait-list usual care group
The wait-list usual care group follows usual care and usual activities.
Participants receive a lifestyle program after the intervention period of six months: this includes two personalized behavioural coaching sessions and any material that the intervention group also received.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in cancer-related fatigue
Time Frame: Baseline till six months
|
Cancer-related fatigue is assessed with the FACIT-Fatigue Scale, a 13 item questionnaire with scores ranging from 0-52.
A score below 34 indicates fatigue.
The minimal clinically important difference is reported to be 3.0 for this scale.
|
Baseline till six months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cancer-related fatigue
Time Frame: Twelve months
|
Cancer-related fatigue is assessed with the FACIT-Fatigue Scale, a 13 item questionnaire with scores ranging from 0-52.
A score below 34 indicates fatigue.
The minimal clinically important difference is reported to be 3.0 for this scale.
|
Twelve months
|
Skeletal muscle fat infiltration and muscle circumference
Time Frame: Baseline and six months
|
Echo intensity of the skeletal muscle rectus femoris, lateral gastrocnemius and biceps brachialis is measured using a portable ultrasound machine.
|
Baseline and six months
|
Gut microbiota composition
Time Frame: Baseline and six months
|
Faecal samples are collected and the microbiota composition in this will be analyzed.
The investigators will use 16S rRNA sequencing data for the taxonomic characterization of the gut microbiota.
Eventually shotgun sequencing may also be done.
|
Baseline and six months
|
Health-related quality of life
Time Frame: Baseline and six months
|
Health-related quality of life is measured with the Functional Assessment of Cancer Therapy - General (FACT-G) questionnaire, which contains the following domains of well-being: physical, social/family, emotional and functional.
The 27-item questionnaire has scores ranging from 0 to 108.
|
Baseline and six months
|
Physical performance (3-minute step test)
Time Frame: Baseline and six months
|
This test indicates cardiovascular fitness by heart rate measurement for one minute after the completion of three minutes of stepping.
|
Baseline and six months
|
Physical performance (5 times sit-to-stand test)
Time Frame: Baseline and six months
|
This test indicates lower extremity skeletal muscle strength.
The time necessary to achieve the standing position on the 5th repetition is measured.
|
Baseline and six months
|
Physical performance (tandem test)
Time Frame: Baseline and six months
|
This test measures balance for three different standing positions.
Each position has to be maintained for 10 seconds in order to pass the test.
|
Baseline and six months
|
Physical performance (chair sit-and-reach test)
Time Frame: Baseline and six months
|
This test measures lower extremity and lower back flexibility.
Participants sit on a chair and bend forward and reach for their toes.
The distance between the hand and toes is measured.
|
Baseline and six months
|
Physical performance (strength: hand dynamometer)
Time Frame: Baseline and six months
|
This test uses a hand dynamometer to measure strength.
|
Baseline and six months
|
Sleep quality and duration (Pittsburgh Sleep Quality Index)
Time Frame: Baseline, six months and 12 months
|
Sleep quality is measured with the Pittsburgh Sleep Quality Index (PSQI), a 19-item questionnaire with scores ranging from 0-21.
A score above 5 indicates bad sleep quality.
|
Baseline, six months and 12 months
|
Sleep quality and duration (Consensus sleep diary morning)
Time Frame: Baseline and six months
|
The Consensus sleep diary morning (CSD), a 15-item diary, is used for measuring other sleep outcomes such as sleep onset latency and sleep duration.
|
Baseline and six months
|
Depression
Time Frame: Baseline and six months
|
Depression is measured using the 8-item Patient Healthcare Questionnaire (PHQ-8).
It contains 8 items, and scores range from 0-24, with higher scores indicating a higher chance of depression.
|
Baseline and six months
|
Anxiety
Time Frame: Baseline and six months
|
Anxiety is measured using the 7-item Generalized Anxiety Disorder (GAD-7).
The GAD-7 contains 7 items, its scores range from 0-21, with higher scores indicating a higher chance of anxiety.
|
Baseline and six months
|
Behavioural determinants
Time Frame: Baseline, three months, six months and twelve months.
|
Identified behavioural determinants through focus groups and a systematic review, are assessed using a self-reported questionnaire with questions based on previous reported questions on different determinants.
These were adapted to reflect the WCRF guidelines.
Higher scores for each of the determinants (scale 1-7) indicate better results.
|
Baseline, three months, six months and twelve months.
|
Habitual dietary intake (Food Frequency Questionnaire)
Time Frame: Baseline, six months and twelve months
|
Nutritional intake is measured using a semi-quantitative Food Frequency Questionnaire (FFQ).
Scores are calculated using the Dutch National Food Consumption tables.
In addition, the validated questionnaire Eetscore is used, which contains a short online questionnaire (10-15 minutes) that serves as an indicator to assess diet quality, based on the Dutch Healthy Diet index 2015 (DHD15-index).
Scores range from 0-160, with higher scores indicating better diet quality.
|
Baseline, six months and twelve months
|
Habitual dietary intake (Eetscore)
Time Frame: Baseline, three months, six months and twelve months
|
Nutritional intake is also measured using the validated questionnaire Eetscore, which uses a short online questionnaire (10-15 minutes) that serves as an indicator to assess diet quality, based on the Dutch Healthy Diet index 2015 (DHD15-index).
Scores range from 0-160, with higher scores indicating better diet quality.
|
Baseline, three months, six months and twelve months
|
Physical activity level (Short QUestionnaire to ASsess Health-enhancing physical activity)
Time Frame: Baseline, three months, six months and twelve months
|
Physical activity is measured using the Short QUestionnaire to ASsess Health-enhancing physical activity (SQUASH).
The questions in the SQUASH are pre-structured in commuting, leisure time, household and work/school activities.
Scores will be assigned to the different reported activities base on intensities in MET and translated to minutes of physical activity.
|
Baseline, three months, six months and twelve months
|
Physical activity level (Accelerometer)
Time Frame: Baseline and six months
|
Physical activity is also measured using ActivPalTM Micro3, an accelerometer measuring sedentary behaviour and physical activity.
The ActivPalTM is worn for 9 days.
|
Baseline and six months
|
Anthropometric measurements (Height)
Time Frame: Baseline and six months
|
Height (in cm) is measured with a stadiometer.
|
Baseline and six months
|
Anthropometric measurements (Weight)
Time Frame: Baseline, three months (self-reported) and six months
|
Weight (in kg) is measured with a calibrated scale.
|
Baseline, three months (self-reported) and six months
|
Anthropometric measurements (Waist circumference)
Time Frame: Baseline and six months
|
Waist circumference (in cm) is measured using tape measures.
|
Baseline and six months
|
Cost-effectiveness evaluation
Time Frame: Baseline, three months and six months
|
The cost-effectiveness of the intervention is evaluated using a questionnaire that includes items on for example costs that the participant has made in order to follow the lifestyle program.
|
Baseline, three months and six months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood pressure
Time Frame: Baseline and six months
|
Blood pressure is measured using a sphygmomanometer.
Both diastolic and systolic blood pressure are measured.
|
Baseline and six months
|
Heart rate
Time Frame: Baseline and six months
|
Heart rate is measured using a sphygmomanometer.
|
Baseline and six months
|
Chrono-nutrition
Time Frame: Baseline and six months
|
Chrono-nutrition, the timing of dietary intake, is measured with the "Chromes vragenlijst patiënten eetpatronen".
This is a Dutch questionnaire containing 26 items that assess meal regularity (8-items), meal frequency (7-items), and meal clock time (11-items).
|
Baseline and six months
|
Colorectal cancer related complaints
Time Frame: Baseline and six months
|
Measuring colorectal cancer specific problems is done using the additional concerns (i.e.
subscale) of the Functional Assessment of Cancer Therapy - Colorectal (FACT-C).
This questionnaire contains 9 items and scores are ranging from 0-28 points.
|
Baseline and six months
|
Hemoglobin levels
Time Frame: Baseline and six months
|
Finger prick blood sampling is used for assessing haemoglobin status as an indicator for anaemia.
|
Baseline and six months
|
Sociodemographic information
Time Frame: Baseline (and six months)
|
Sociodemographic information is collected using standardized questionnaires.
|
Baseline (and six months)
|
Clinical parameters
Time Frame: Baseline (and six months)
|
Clinical parameters such as time since diagnosis, current and received treatment, comorbidities and medicine use, are collected either via standardized questionnaires or from medical records (part of informed consent).
|
Baseline (and six months)
|
Collaborators and Investigators
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NL75999.091.21
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Cancer
-
University of California, San FranciscoCompletedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRectal Cancer | Colon Cancer | Cancer Survivor | Colorectal Adenocarcinoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedCancer Survivor | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal Cancer AJCC v8 | Stage IIB Colorectal... and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruitingColorectal Adenocarcinoma | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
City of Hope Medical CenterRecruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Adenocarcinoma | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Neoplasms Malignant | Colorectal Cancer Stage IUnited States, Japan, Italy, Spain
-
Sidney Kimmel Cancer Center at Thomas Jefferson...United States Department of DefenseActive, not recruitingColorectal Adenoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage 0 Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal... and other conditionsUnited States
-
University of Roma La SapienzaCompletedColorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Cancer Stage 0 | Colorectal Cancer Stage IItaly
-
University of Southern CaliforniaNational Cancer Institute (NCI); AmgenTerminatedStage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Colorectal Adenocarcinoma | RAS Wild Type | Stage III Colorectal Cancer AJCC v7 | Stage IIIA Colorectal Cancer AJCC v7 | Stage IIIB Colorectal Cancer AJCC v7 | Stage IIIC Colorectal Cancer...United States
Clinical Trials on Behaviour change guided lifestyle intervention
-
Sheffield Teaching Hospitals NHS Foundation TrustCompletedCystic FibrosisUnited Kingdom
-
Sheffield Teaching Hospitals NHS Foundation TrustCompletedCystic FibrosisUnited Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Allurion TechnologiesCompleted
-
Glasgow Caledonian UniversityKing's College London; St George's, University of London; University of Glasgow; NHS LanarkshireRecruitingIntermittent Claudication | Peripheral Artery DiseaseUnited Kingdom
-
University of JyvaskylaRecruitingInactivity, Physical | Inactivity/Low Levels of ExerciseFinland
-
National University of MalaysiaUniversiti Putra Malaysia; University of RoehamptonCompletedAdolescent Obesity | Adolescent Behavior | Adolescent OverweightMalaysia
-
Second Affiliated Hospital, School of Medicine,...Ningbo Medical Center Lihuili Hospital; The Central Hospital of Lishui City; First... and other collaboratorsCompletedAcute Stroke | Thrombolytic Therapy | Door to Treatment Time | Quality ImprovementChina
-
Concordia University, MontrealCentre de Recherche de l'Institut Universitaire de Geriatrie de MontrealActive, not recruiting
-
Maastricht University Medical CenterMaastricht UniversityActive, not recruitingQuality of Life | Obesity, Childhood | Self Efficacy | Resilience, Psychological | Self Esteem | OptimismIndia